טוען...
Biomarkers in immunotherapy: literature review and future directions
Within the past decade, immunotherapy has revolutionized the treatment of advanced non-small lung cancer (NSCLC). Immune checkpoint inhibitors (ICIs) such as pembrolizumab, nivolumab, atezolizumab, and durvalumab have shown superiority over chemotherapy regimens in patients with programmed death-lig...
שמור ב:
| הוצא לאור ב: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578474/ https://ncbi.nlm.nih.gov/pubmed/33145089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.15 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|